Press releases | WebDisclosure

PRESS RELEASE

published on 06/04/2024 at 08:00, 1 year 8 months ago

Valbiotis reaches an agreement to terminate its licensing and supply agreement with Nestlé Health Science
Valbiotis terminates licensing and supply agreement with Nestlé Health Science, securing full ownership of TOTUM•63 for diabetes treatment. Strategic control and future partnerships planned

Licensing Agreement Valbiotis Diabetes Treatment TOTUM•63 Nestlé Health Science
PRESS RELEASE

published on 06/04/2024 at 08:00, 1 year 8 months ago

Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc purchased 97,515 of its ordinary shares on Euronext Dublin and the London Stock Exchange. The repurchased shares will be cancelled as part of the share buyback program

London Stock Exchange Share Buyback Cairn Homes Plc Euronext Dublin Cancellation
PRESS RELEASE

published on 06/04/2024 at 07:30, 1 year 8 months ago

APONTIS PHARMA continues to gear organization towards growth and internationalization – Renowned industry expert leads supply chain management
APONTIS PHARMA appoints renowned industry expert Mila Brückel as Head of Supply Chain, gearing organization towards growth and internationalization

Pharmaceutical Industry Supply Chain Management APONTIS PHARMA Internationalization Mila Brückel
PRESS RELEASE

published on 06/04/2024 at 07:30, 1 year 8 months ago

DATAGROUP is the first provider to introduce electronic files for BAföG in education support offices
DATAGROUP introduces electronic files for BAföG applications in education support offices, enhancing digitalization and automation processes

Automation DATAGROUP Digitalization BAföG Electronic Files
PRESS RELEASE

published on 06/04/2024 at 07:30, 1 year 8 months ago

Inside Information / Other news releases
GenSight Biologics to present at key medical and stakeholder meetings, including 16th Meeting of the EUNOS. Papers on LUMEVOQ® for LHON to be showcased

Gene Therapy GenSight Biologics Medical Conferences LUMEVOQ Retinal Neurodegenerative Diseases
PRESS RELEASE

published on 06/04/2024 at 07:30, 1 year 8 months ago

Vallourec Presents Its Leading Technology Center and New Energies Solutions to Investors
Vallourec showcases its technology center and new energy solutions to investors, highlighting R&D, hydrogen storage innovation, and strategic targets for 2030

Investors R&D Technology Center Vallourec New Energies
PRESS RELEASE

published on 06/04/2024 at 07:30, 1 year 8 months ago

Informations privilégiées / Autres communiqués
AFYREN confirme le succès de ses cycles de production et son objectif de démarrage en continu en 2024 pour livrer des volumes commerciaux d'acides biosourcés, grâce à sa technologie unique

Chimie Verte AFYREN Acides Biosourcés Cycles De Production Démarrage En Continu
PRESS RELEASE

published on 06/04/2024 at 07:30, 1 year 8 months ago

Informations privilégiées / Autres communiqués
GenSight Biologics va présenter ses thérapies géniques innovantes pour les maladies neurodégénératives lors de conférences médicales et scientifiques importantes

Thérapie Génique GenSight Biologics Maladies Neurodégénératives Conférences Médicales Présentations Scientifiques
PRESS RELEASE

published on 06/04/2024 at 07:30, 1 year 8 months ago

Vallourec présente aux investisseurs son centre technologique de pointe et ses applications en matière de Nouvelles Energies
Vallourec présente son centre technologique de pointe et ses applications dans les Nouvelles Energies lors d'une visite à Aulnoye-Aymeries. La R&D et l'innovation, ainsi que la solution Delphy de stockage vertical d'hydrogène, sont au cœur de la stratégie

R&D Investisseurs Vallourec Nouvelles Énergies Stockage Vertical D'hydrogène
PRESS RELEASE

published on 06/04/2024 at 07:30, 1 year 8 months ago

Inside Information / Other news releases
AFYREN achieves successful completion of long production cycles for commercial volumes of acids, confirms the objective to start continuous production in 2024 at AFYREN NEOXY plant

Green Chemistry AFYREN Continuous Production Production Cycles Commercial Volumes

Published on 02/21/2026 at 00:45, 1 day 4 hours ago

Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 1 day 4 hours ago

Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:15, 1 day 5 hours ago

DigiPower X Announces Closing of Settlement
Published on 02/20/2026 at 23:00, 1 day 5 hours ago

Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 1 day 6 hours ago

Organto Foods Completes Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 02/21/2026 at 12:00, 16 hours 54 minutes ago

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/21/2026 at 12:00, 16 hours 54 minutes ago

Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Published on 02/20/2026 at 18:36, 1 day 10 hours ago

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 1 day 10 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:23, 1 day 10 hours ago

POS-Transaction in Own Shares

View all EQS

Published on 02/20/2026 at 19:29, 1 day 9 hours ago

SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 1 day 9 hours ago

SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 1 day 10 hours ago

TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 18:00, 1 day 10 hours ago

TERACT - Résiliation du contrat de liquidité
Published on 02/20/2026 at 17:35, 1 day 11 hours ago

CHIFFRE D'AFFAIRES 2025

View all LES ECHOS COMFI WIRE

News